Sichenzia Ross Ference advised Beyond Air Inc. (Nasdaq: XAIR) on the uplisting
Beyond Air, Inc. operates as a medical device and biopharmaceutical company. The Company focuses on the discovery and development of a nitric oxide formulation and delivery systems to treat various respiratory diseases. Beyond Air serves patients and customers in the United States and Israel.
Sichenzia Ross Ference advised Beyond Air Inc. with a team led by Gregory Sichenzia (Picture).
Involved fees earner: Gregory Sichenzia – Sichenzia Ross Ference LLP;
Law Firms: Sichenzia Ross Ference LLP;
Clients: Beyond Air, Inc. ;